BRÈVE

sur AI/ML Innovations Inc. (CVE:AIML)

AI/ML Innovations Inc. Appoints Dr. Paul Dorian to Lead Medical Advisory Board

AI/ML Innovations Inc. has appointed Dr. Paul Dorian as its Medical Innovation Architect and head of the Medical Advisory Board. Dr. Dorian, a globally recognized cardiologist, brings expertise in cardiac electrophysiology and clinical research. He succeeds Peter Kendall in this role as the company advances its AI-driven cardiac diagnostic technologies.

Dr. Dorian has collaborated with AI/ML Innovations over recent months, influencing product strategy and innovation across the company’s platforms. His appointment aims to enhance the company's clinical leadership as it enters a phase of clinical validation and global deployment.

Paul Duffy, CEO, remarked on Dr. Dorian's unparalleled expertise and leadership, emphasizing its impact on ensuring the clinical relevance, safety, and impact of the company’s technologies as they expand into regulated markets.

R. H.

Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de AI/ML Innovations Inc.